ASCO21

Saad Z. Usmani, MD, MBA, FACPMyeloma | November 14, 2022
Janssen and Legend Biotech announced new data for BCMA-directed CAR-T cell therapy cilta-cel for relapsed/refactory MM.
Advertisement
Advertisement
Advertisement
Advertisement